Floatz logo

Abbv-932

Bipolar II Disorder

AbbViePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

21 Active assets in the Bipolar II Disorder cohort.

Asset / SponsorPhaseRating
Lurasidone
Massachusetts General Hospital
Phase 4BBB
Seroquel®
First Affiliated Hospital of Zhejiang University
Phase 4BB
Valproic Acid
National Cheng-Kung University Hospital
Phase 4BB
VENLOR
Stanley Medical Research Institute
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Joshua Rosenblat
Phase 4BB

View all 37 →

Same molecule, other indications

Abbv-932 is also rated in:

bipolar I disorderDormant
B
Indicative ·
57 / 100
View asset →
Healthy VolunteersDormant
CC
Indicative ·
44 / 100
View asset →
bipolar disorderDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →